Evidence map›Paper›PMID 40176864›Full record

ArticleBioMedicine2025

Acute phantosmia as the first manifestaton of brain metastases in a patient with breast cancer. Case report.

Georgios I Papageorgiou, Nikolaos Skouteris

Abstract readCase Reports
In one paragraph

Article in BioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Georgios I Papageorgiou *2nd Medical Oncology Department, IASO General Clinic, Athens, Greece.
Nikolaos Skouteris *Division of Medical Oncology & Hematopoietic Cell Transplant Unit, Department of Medicine, "Metaxa" Cancer Hospital, 51 Botassi Street, 18537 Piraeus, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phantosmia belongs to the group of olfactory dysfunctions. It is more commonly described in psychiatric conditions and some cases of viral infections, but it has been also rarely described in cancer patients who develop primary or metastatic central nervous system tumors; the early identification of this symptom in this population is crucial, as it could lead to timely diagnosis and treatment through a multidisciplinary approach. With the current report we present the case of a 60-year-old lady with metastatic breast cancer and without known preexisting brain metastases, who developed acute phantosmia without other neurological deficits; computed tomography of the brain revealed multiple brain metastases, which were attributed to the malignancy, and for which she was effectively treated with whole brain irradiation and antipsychotic as well as anticonvulsant medications. Furthermore, we underline the value of cooperation between the various specialties that could aid in diagnosis and management of this symptomatology. Phantosmia is an extremely rare symptom in cancer patients, and its appearance should alarm physicians to rapidly investigate a possible progression of disease in the central nervous system. Multidisciplinary approach is needed for the optimal management of these patients.

Indexed as

Brain metastasesCancerMultidisciplinaryOlfactoryPhantosmia

Identifiers

PMID40176864
PMCPMC11959957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.